New products
RenovoRx reports RenovoCath’s first clinical use in sarcoma
RenovoRx announced the first commercial clinical use of its RenovoCath device in treating a sarcoma patient. RenovoCath is a catheter-based delivery system designed for localized cancer therapy. The milestone marks initial market adoption of the device following prior regulatory or clinical milestones.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network